Worldwide: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Northern Advantage: Canada's Federal Court As A Venue For Pharmaceutical Patent Litigation

In the complex and high-stakes world of pharmaceutical patent litigation, selecting the right venue can significantly influence the outcome of a case. For companies marketing or seeking to market pharmaceuticals in Canada...

BJ

Bennett Jones LLP

Deference Prevails: A Public Drug Funding Decision In Québec Is Upheld On Reasonableness Review

In Avir Pharma Inc. c. Minister of Health and Social Services1, the Québec Superior Court dismissed an application for judicial review challenging the Minister’s refusal to include Jorveza—a drug used to treat...

Canada Healthcare

TL

Torys LLP

Tout ce qu'il faut savoir sur les lignes directrices mises à jour et les exemples 2026 de l'OPIC concernant l'objet brevetable

Le 25 mars 2026, l'Office de la propriété intellectuelle du Canada (l'« OPIC ») a publié de nouvelles lignes directrices concernant l'interprétation...

SB

Smart & Biggar

Canada Announces New Pharmaceutical And Life Sciences Sector Task Force

On March 18, 2026, the federal Minister of Health announced the creation of the Pharmaceutical and Life Sciences Sector Task Force, a joint initiative led by Health Canada and Innovation...

Canada Healthcare

SB

Smart & Biggar

PMPRB Consults On Proposed Practice Directions For PMPRB Hearings

SB

Smart & Biggar

Le CEPMB lance une consultation concernant le projet de directives relatives à la pratique pour ses audiences

Canada Technology

SB

Smart & Biggar

Changing Life Sciences' Patent Landscape: It's Time To Talk About Efficient Licensing

GW

Gowling WLG

L'intelligence artificielle prescrira-t-elle bientôt des médicaments au Canada? Les leçons du programme novateur de l'Utah

Canada Healthcare

FF

Fasken (French)

Updated Guidance From CIPO On Patentable Subject-Matter

ML

McMillan LLP

Torys On Defence: The Role Of Life Sciences In Canada's Defence Capabilities

Canada Healthcare

TL

Torys LLP

Could Artificial Intelligence Soon Prescribe Drugs In Canada? Lessons From Utah's Landmark Program

Canada Healthcare

F

Fasken

PMPRB Launches Consultation On Proposed Practice Directions For Hearings

Canada Healthcare

MT

McCarthy Tétrault LLP

Federal Court Denies Class Action Certification In Generic Drug Price Fixing Case

Canada Healthcare

SB

Smart & Biggar

La Cour fédérale rejette une requête en autorisation de recours collectif relative à la fixation des prix de médicaments génériques

Canada Healthcare

SB

Smart & Biggar

2026 Ontario Budget: Enhanced HST Relief On New Homes

Canada Real Estate

AB

Aird & Berlis LLP

International Crypto Fraud Crackdown: How CRA Treats Tax Losses From Crypto Scams In Canada

RS

Rotfleisch & Samulovitch P.C.

CRA Trust Reporting Requirements In Canada: T3 Filing Rules, Bare Trust Updates & Tax Audit Risk

RS

Rotfleisch & Samulovitch P.C.

Cyber Criminals Love Your Deals: How Hidden Cyber Risk Can Blow Up Your M&A (And What To Do About It)

MT

Miller Thomson LLP

Distinguishing Between Disciplinable Gossip And Actionable Good Faith Concerns In The Workplace

Canada Employment

RG

Roper Greyell LLP – Employment and Labour Lawyers

Update On Proposed Ministerial Reliance Order

As we reported last month, the Minister of Health launched a consultation on a proposed Ministerial Reliance Order that would permit Health Canada to complete the examination of certain parts...

Canada Healthcare

SB

Smart & Biggar

Mise à jour sur la proposition d'arrêté ministériel relatif à la confiance

Comme nous l'avons indiqué le mois dernier, la ministre de la Santé a lancé une consultation sur une proposition d'arrêté ministériel relatif à la confiance qui permettrait...

Canada Healthcare

SB

Smart & Biggar

L'Agence des médicaments du Canada annonce une consultation sur le processus d'examen simplifié et de nouvelles procédures en ce qui concerne les reconsidérations et les nouvelles demandes d'examen

Le 29 janvier 2026, l'Agence des médicaments du Canada (l'« AMC ») a publié des Améliorations au processus d'examen en vue du remboursement d'un médicament...

Canada Healthcare

SB

Smart & Biggar

Canada's Drug Agency Announces Consultation On Streamlined Review Process And New Reconsideration/resubmission Procedures

On January 29, 2026, Canada's Drug Agency (CDA) published Improvements to the Drug Reimbursement Review Process, which includes a section for consultation on proposed changes to the reimbursement review process.

Canada Healthcare

SB

Smart & Biggar

New PMPRB Chairperson And PMPRB Releases January 2026 NEWSletter

Canada Healthcare

SB

Smart & Biggar

Nouvelle présidente au CEPMB et publication de l'édition de janvier 2026 de la Nouvelle du CEPMB

SB

Smart & Biggar

U.S. Supreme Court Strikes Down Key Trump Tariffs, But New Measures May Follow

Canada International

GW

Gowling WLG

Healthcare Supply Chains: Managing Modern Slavery Risks In Hospital Procurement

Canada Healthcare

BL

Borden Ladner Gervais LLP

Une proposition d'arrêté ministériel relatif à la confiance pourrait permettre à Santé Canada d'avoir recours à des décisions prises par des autorités réglementaires étrangères reconnues

Canada Healthcare

SB

Smart & Biggar

Les 10 articles incontournables de la Mise à jour en PI Rx en 2025

Canada Healthcare

SB

Smart & Biggar

Top Ten Rx IP Update Reads Of 2025

SB

Smart & Biggar

Top Ten Rx IP Update Reads Of 2025

SB

Smart & Biggar

Les faits saillants de 2025 au Canada en matière de PI en sciences de la vie et de droit réglementaire

Canada Healthcare

SB

Smart & Biggar

2025 Highlights In Canadian Life Sciences IP And Regulatory Law

Canada Healthcare

SB

Smart & Biggar

Top Ten Rx IP Update Reads Of 2025

Below are Rx IP Update's most-read articles of 2025...

SB

Smart & Biggar

Top Ten Rx IP Update Reads Of 2025

Below are Rx IP Update's most-read articles of 2025...

SB

Smart & Biggar

Les faits saillants de 2025 au Canada en matière de PI en sciences de la vie et de droit réglementaire

En 2025, l'équipe responsable des mises à jour PI Rx chez Smart & Biggar s'est penchée sur un certain nombre de nouveautés en matière de PI en sciences de la vie et de droit réglementaire.

Canada Healthcare

SB

Smart & Biggar

2025 Highlights In Canadian Life Sciences IP And Regulatory Law

In 2025, the Rx IP Update team at Smart & Biggar reported on a number of developments in Canadian life sciences IP and regulatory law. Highlights from 2025 are below.

Canada Healthcare

SB

Smart & Biggar

Santé Canada lance une consultation sur deux documents d'ébauche de lignes directrices sur les conditions pour les médicaments à usage humain et vétérinaire ainsi que les présentations de drogues basées sur des preuves prometteuses d'efficacité clinique

Canada Healthcare

SB

Smart & Biggar

Proposed New Requirements For Lithium-Ion Batteries In Consumer Products

Health Canada has published a Notice of Intent regarding proposed regulations for lithium-ion batteries and consumer products containing lithium-ion batteries (under the Canada Consumer Product Safety Act ("CCPSA")).

Canada Consumer

GR

Gardiner Roberts LLP

How Is AI Transforming The Life Sciences Industry?

Stakeholders are grappling with the numerous opportunities and risks presented by the convergence of artificial intelligence and tools designed for the development of novel therapeutics and the delivery of health care.

Canada Technology

TL

Torys LLP

What You Should Know About The Freestyle Libre 3 Recall

There is little doubt that medical technology has dramatically enhanced the quality and longevity of our lives. We continue to see innovations that not only aid in earlier detection of disease...

Worldwide Litigation

GP

Gluckstein Lawyers

VC Investment In Canada For Life Sciences Companies

Despite recent pullbacks in biotechnology and life sciences venture capital ("VC") funding in Canada, a more in-depth analysis reveals strong indicators of investment demand...

Canada Healthcare

MT

McCarthy Tétrault LLP

Mise à jour sur le CEPMB : Entrée en vigueur des Lignes directrices pour le personnel du CEPMB le 1er janvier 2026 et Rapport annuel 2024

Canada Healthcare

SB

Smart & Biggar

PMPRB Update: Guidelines For PMPRB Staff Come Into Effect January 1, 2026; 2024 Annual Report

Canada Healthcare

SB

Smart & Biggar

Medical Devices Updates: Phase II Consultation On Medical Devices Regulations Amendments, Medical Device Licences Guidance And IMDRF Table Of Contents Guidance

Canada Healthcare

SB

Smart & Biggar

Mise à jour sur les instruments médicaux : Phase II de la consultation sur les modifications au Règlement sur les instruments médicaux, et lignes directrices sur l'homologation d'instruments médicaux et sur la table des matières de l'IMDRF

Canada Healthcare

SB

Smart & Biggar

Santé Canada et la Food and Drug Administration des États-Unis conviennent de mettre en place un programme de partage d'informations pour l'examen des médicaments génériques

Canada Healthcare

SB

Smart & Biggar

L'Agence des médicaments du Canada publie une nouvelle ressource et des données sur le processus d'autorisation et de remboursement des médicaments

Canada Healthcare

SB

Smart & Biggar

Health Canada And U.S. FDA Agree To Establish Information Sharing Program For Generic Drug Submission Reviews

Canada Healthcare

SB

Smart & Biggar

Health Canada Proposes Amendments To MDEL Holders And Applicants

Worldwide Healthcare

BJ

Bennett Jones LLP

Consultation sur les modifications proposées aux exigences relatives aux licences d'établissement d'instruments médicaux

Canada Healthcare

BC

Blake, Cassels & Graydon LLP

Practical Tips On Patent Term Adjustment In Canada

BL

Borden Ladner Gervais LLP

L'APP lance une voie révisée pour les négociations non complexes concernant le prix de médicaments

Canada Healthcare

SB

Smart & Biggar

December 2025 Rosen Sunshine Newsletter

Canada Healthcare

RS

Rosen Sunshine LLP

L'Ontario propose des mesures législatives pour encadrer les réseaux de fournisseurs privilégiés

Canada Healthcare

SB

Smart & Biggar

Branding Medical Devices: Balancing Brand Protection And Regulation

Canada Healthcare

ML

McMillan LLP

Ontario proposes legislation to regulate preferred provider networks

Canada Healthcare

SB

Smart & Biggar

See more

Latest Videos

See more

Lois canadiennes, américaines, britanniques et européennes entourant l'Internet des objets (Video)

BL

Borden Ladner Gervais LLP

The Legal Steps To Startups: Health & Life Science (Video)

PM

Parlee McLaws

Navigating (and Challenging) A Changing Life Sciences Regulatory Environment (Video)

TL

Torys LLP

Le Secteur De La Santé Au Canada Après La COVID-19 : Perspectives Juridiques, Médicales Et Commerciales (vidéos)

SE

Stikeman Elliott LLP

Lifecycle Of A Smart Idea: Patent Strategy - Optimising Life Sciences Patents (Video)

GW

Gowling WLG

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More